Institutional investors are piling into this small cap private sector bank. Let’s find out why.
This midcap tech company drew strong buying interest from FIIs and DIIs in Q3FY26. This was amid the IT sell-off.…
Zota Health has been rapidly expanding, revenues are increasing multifold, but losses are deepening at the same time. Are institutional…
DIIs are raising stakes across Indian equities, and during Q3FY26, these three stocks top their priorities. Explore the stocks and…
FIIs bought select stocks from the Indian market during Q3FY26 while remaining net sellers overall. Explore these stocks and find…
The media industry has been down for over a year, but there is one stock that has been getting all…
Virtually Zero-debt, high dividend stocks not only potentially offer regular income but also a sense of safety and stability. Explore…
Despite the sharp correction in the Nifty IT index, DIIs are buying IT stocks at an aggressive pace. Are they…
FIIs and DIIs do not often bet on the same stock, but when they do, there must be something interesting.…
Despite a sluggish energy sector and falling stock prices, FIIs invested in this energy stock through the July-September quarter. Are…
While FIIs are dropping most realty stocks from their portfolio, they added this one stock at an aggressive pace –…
This is the only defence stock both FIIs and DIIs are still buying significantly, driven by its strong order book,…
DIIs are driving market stability with consistent buying despite FII outflows. Their rising stake in Crompton, MCX, and Coforge show…
FIIs and DIIs together invested heavily in these two stocks – one is from the banking sector, another from pharma,…
FIIs offloaded Indian equities yet added to two high-conviction bets—Cartrade Tech and Ixigo—where they already hold 60%+. Strong growth, tech…
Despite heavy FII selling in Q2FY26, DIIs showed strong confidence in India’s growth story, investing ₹1.64 lakh crore. Top DII…
Amidst heavy sell-off by FIIs during the July-September quarter, they bought some select stocks driven by strong fundamentals, business prospects,…
Three pharma companies that have delivered the highest average 5-year ROCE are all into manufacturing the same type of products.…
